Expression of Cpgp40/15 in Toxoplasma gondii: A surrogate system for the study of cryptosporidium glycoprotein antigens

R. M. O'Connor, K. Kim, F. Khan, H. D. Ward

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Cryptosporidium parvum is a waterborne enteric coccidian that causes diarrheal disease in a wide range of hosts. Development of successful therapies is hampered by the inability to culture the parasite and the lack of a transfection system for genetic manipulation. The glycoprotein products of the Cpgp40/15 gene, gp40 and gp15, are involved in C. parvum sporozoite attachment to and invasion of host cells and, as such, may be good targets for anticryptosporidial therapies. However, the function of these antigens appears to be dependent on the presence of multiple O-linked α -N-acetylgalactosamine (α-GalNAc) determinants. A eukaryotic expression system that would produce proteins bearing glycosylation patterns similar to those found on the native C. parvum glycoproteins would greatly facilitate the molecular and functional characterization of these antigens. As a unique approach to this problem, the Cpgp40/15 gene was transiently expressed in Toxoplasma gondii, and the expressed recombinant glycoproteins were characterized. Antisera to gp40 and gp15 reacted with the surface membranes of tachyzoites expressing the Cpgp40/15 construct, and this reactivity colocalized with that of antiserum to the T. gondii surface protein SAG1. Surface membrane localization was dependent on the presence of the glycophosphatidylinositol anchor attachment site present in the gp15 coding sequence. The presence of terminal O-linked α-GalNAc determinants on the T. gondii recombinant gp40 was confirmed by reactivity with Helix pomatia lectin and the monoclonal antibody 4E9, which recognizes α-GalNAc residues, and digestion with α-N-acetylgalactosaminidase. In addition to appropriate localization and glycosylation, T. gondii apparently processes the gp40/15 precursor into the gp40 and gp15 component glycopolypeptides, albeit inefficiently. These results suggest that a surrogate system using T. gondii for the study of Cryptosporidium biology may be useful.

Original languageEnglish (US)
Pages (from-to)6027-6034
Number of pages8
JournalInfection and Immunity
Volume71
Issue number10
DOIs
StatePublished - Oct 1 2003

Fingerprint

Cryptosporidium
Toxoplasma
Glycoproteins
Cryptosporidium parvum
Antigens
Glycosylation
Immune Sera
Acetylgalactosamine
Sporozoites
Membranes
Host Specificity
Genes
Transfection
Digestion
Membrane Proteins
Parasites
Monoclonal Antibodies
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Expression of Cpgp40/15 in Toxoplasma gondii : A surrogate system for the study of cryptosporidium glycoprotein antigens. / O'Connor, R. M.; Kim, K.; Khan, F.; Ward, H. D.

In: Infection and Immunity, Vol. 71, No. 10, 01.10.2003, p. 6027-6034.

Research output: Contribution to journalArticle

O'Connor, R. M. ; Kim, K. ; Khan, F. ; Ward, H. D. / Expression of Cpgp40/15 in Toxoplasma gondii : A surrogate system for the study of cryptosporidium glycoprotein antigens. In: Infection and Immunity. 2003 ; Vol. 71, No. 10. pp. 6027-6034.
@article{6940acf8c9694a5f90a271de30db87b9,
title = "Expression of Cpgp40/15 in Toxoplasma gondii: A surrogate system for the study of cryptosporidium glycoprotein antigens",
abstract = "Cryptosporidium parvum is a waterborne enteric coccidian that causes diarrheal disease in a wide range of hosts. Development of successful therapies is hampered by the inability to culture the parasite and the lack of a transfection system for genetic manipulation. The glycoprotein products of the Cpgp40/15 gene, gp40 and gp15, are involved in C. parvum sporozoite attachment to and invasion of host cells and, as such, may be good targets for anticryptosporidial therapies. However, the function of these antigens appears to be dependent on the presence of multiple O-linked α -N-acetylgalactosamine (α-GalNAc) determinants. A eukaryotic expression system that would produce proteins bearing glycosylation patterns similar to those found on the native C. parvum glycoproteins would greatly facilitate the molecular and functional characterization of these antigens. As a unique approach to this problem, the Cpgp40/15 gene was transiently expressed in Toxoplasma gondii, and the expressed recombinant glycoproteins were characterized. Antisera to gp40 and gp15 reacted with the surface membranes of tachyzoites expressing the Cpgp40/15 construct, and this reactivity colocalized with that of antiserum to the T. gondii surface protein SAG1. Surface membrane localization was dependent on the presence of the glycophosphatidylinositol anchor attachment site present in the gp15 coding sequence. The presence of terminal O-linked α-GalNAc determinants on the T. gondii recombinant gp40 was confirmed by reactivity with Helix pomatia lectin and the monoclonal antibody 4E9, which recognizes α-GalNAc residues, and digestion with α-N-acetylgalactosaminidase. In addition to appropriate localization and glycosylation, T. gondii apparently processes the gp40/15 precursor into the gp40 and gp15 component glycopolypeptides, albeit inefficiently. These results suggest that a surrogate system using T. gondii for the study of Cryptosporidium biology may be useful.",
author = "O'Connor, {R. M.} and K. Kim and F. Khan and Ward, {H. D.}",
year = "2003",
month = "10",
day = "1",
doi = "10.1128/IAI.71.10.6027-6034.2003",
language = "English (US)",
volume = "71",
pages = "6027--6034",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Expression of Cpgp40/15 in Toxoplasma gondii

T2 - A surrogate system for the study of cryptosporidium glycoprotein antigens

AU - O'Connor, R. M.

AU - Kim, K.

AU - Khan, F.

AU - Ward, H. D.

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Cryptosporidium parvum is a waterborne enteric coccidian that causes diarrheal disease in a wide range of hosts. Development of successful therapies is hampered by the inability to culture the parasite and the lack of a transfection system for genetic manipulation. The glycoprotein products of the Cpgp40/15 gene, gp40 and gp15, are involved in C. parvum sporozoite attachment to and invasion of host cells and, as such, may be good targets for anticryptosporidial therapies. However, the function of these antigens appears to be dependent on the presence of multiple O-linked α -N-acetylgalactosamine (α-GalNAc) determinants. A eukaryotic expression system that would produce proteins bearing glycosylation patterns similar to those found on the native C. parvum glycoproteins would greatly facilitate the molecular and functional characterization of these antigens. As a unique approach to this problem, the Cpgp40/15 gene was transiently expressed in Toxoplasma gondii, and the expressed recombinant glycoproteins were characterized. Antisera to gp40 and gp15 reacted with the surface membranes of tachyzoites expressing the Cpgp40/15 construct, and this reactivity colocalized with that of antiserum to the T. gondii surface protein SAG1. Surface membrane localization was dependent on the presence of the glycophosphatidylinositol anchor attachment site present in the gp15 coding sequence. The presence of terminal O-linked α-GalNAc determinants on the T. gondii recombinant gp40 was confirmed by reactivity with Helix pomatia lectin and the monoclonal antibody 4E9, which recognizes α-GalNAc residues, and digestion with α-N-acetylgalactosaminidase. In addition to appropriate localization and glycosylation, T. gondii apparently processes the gp40/15 precursor into the gp40 and gp15 component glycopolypeptides, albeit inefficiently. These results suggest that a surrogate system using T. gondii for the study of Cryptosporidium biology may be useful.

AB - Cryptosporidium parvum is a waterborne enteric coccidian that causes diarrheal disease in a wide range of hosts. Development of successful therapies is hampered by the inability to culture the parasite and the lack of a transfection system for genetic manipulation. The glycoprotein products of the Cpgp40/15 gene, gp40 and gp15, are involved in C. parvum sporozoite attachment to and invasion of host cells and, as such, may be good targets for anticryptosporidial therapies. However, the function of these antigens appears to be dependent on the presence of multiple O-linked α -N-acetylgalactosamine (α-GalNAc) determinants. A eukaryotic expression system that would produce proteins bearing glycosylation patterns similar to those found on the native C. parvum glycoproteins would greatly facilitate the molecular and functional characterization of these antigens. As a unique approach to this problem, the Cpgp40/15 gene was transiently expressed in Toxoplasma gondii, and the expressed recombinant glycoproteins were characterized. Antisera to gp40 and gp15 reacted with the surface membranes of tachyzoites expressing the Cpgp40/15 construct, and this reactivity colocalized with that of antiserum to the T. gondii surface protein SAG1. Surface membrane localization was dependent on the presence of the glycophosphatidylinositol anchor attachment site present in the gp15 coding sequence. The presence of terminal O-linked α-GalNAc determinants on the T. gondii recombinant gp40 was confirmed by reactivity with Helix pomatia lectin and the monoclonal antibody 4E9, which recognizes α-GalNAc residues, and digestion with α-N-acetylgalactosaminidase. In addition to appropriate localization and glycosylation, T. gondii apparently processes the gp40/15 precursor into the gp40 and gp15 component glycopolypeptides, albeit inefficiently. These results suggest that a surrogate system using T. gondii for the study of Cryptosporidium biology may be useful.

UR - http://www.scopus.com/inward/record.url?scp=0141780894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141780894&partnerID=8YFLogxK

U2 - 10.1128/IAI.71.10.6027-6034.2003

DO - 10.1128/IAI.71.10.6027-6034.2003

M3 - Article

C2 - 14500524

AN - SCOPUS:0141780894

VL - 71

SP - 6027

EP - 6034

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 10

ER -